Nuzenio

Repl

Repl news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 16 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 10:06:07 GMTREPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug - Stocktwits
Sat, 08 Aug 2026 09:56:28 GMTWhy Did REPL, SNOW, NET Stocks Surge To 52-Week Highs Last Week? - Stocktwits
Sat, 08 Aug 2026 04:32:16 GMTReplimune Group Inc. (REPL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Sat, 08 Aug 2026 02:13:38 GMTREPL Sep 2026 14.000 call (REPL260918C00014000) stock price, news, quote and history - Yahoo Finance Australia
Sat, 08 Aug 2026 00:31:00 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - TradingView
Fri, 07 Aug 2026 21:07:00 GMTREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Repl.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

16 distinct publisher/source names are currently connected to this entity page.